Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 39 entries
Sorted by: Best Match Show Resources per page
Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7.

Molecular syndromology

Suspitsin EN, Sokolenko AP, Lyazina LV, Preobrazhenskaya EV, Lepenchuk AY, Imyanitov EN.
PMID: 26557828
Mol Syndromol. 2015 Jul;6(2):96-8. doi: 10.1159/000371408. Epub 2015 Jan 24.

Bardet-Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy characterized by obesity, postaxial polydactyly, retinitis pigmentosa, mental retardation, and kidney abnormalities. At least 19 genes have been shown to be associated with BBS, and therefore, genetic testing is highly...

Cite
Suspitsin EN, Sokolenko AP, Lyazina LV, et al. Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7. Mol Syndromol. 2015;6(2):96-8doi: 10.1159/000371408.
Suspitsin, E. N., Sokolenko, A. P., Lyazina, L. V., Preobrazhenskaya, E. V., Lepenchuk, A. Y., & Imyanitov, E. N. (2015). Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7. Molecular syndromology, 6(2), 96-8. https://doi.org/10.1159/000371408
Suspitsin, Evgeny N, et al. "Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7." Molecular syndromology vol. 6,2 (2015): 96-8. doi: https://doi.org/10.1159/000371408
Suspitsin EN, Sokolenko AP, Lyazina LV, Preobrazhenskaya EV, Lepenchuk AY, Imyanitov EN. Exome Sequencing of a Family with Bardet-Biedl Syndrome Identifies the Common Russian Mutation c.1967_1968delTAinsC in BBS7. Mol Syndromol. 2015 Jul;6(2):96-8. doi: 10.1159/000371408. Epub 2015 Jan 24. PMID: 26557828; PMCID: PMC4574611.
Copy Download .nbib Format: NLM
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.

Hereditary cancer in clinical practice

Suspitsin EN, Sherina NY, Ponomariova DN, Sokolenko AP, Iyevleva AG, Gorodnova TV, Zaitseva OA, Yatsuk OS, Togo AV, Tkachenko NN, Shiyanov GA, Lobeiko OS, Krylova NY, Matsko DE, Maximov SY, Urmancheyeva AF, Porhanova NV, Imyanitov EN.
PMID: 19338682
Hered Cancer Clin Pract. 2009 Feb 25;7(1):5. doi: 10.1186/1897-4287-7-5.

BACKGROUND: A significant portion of ovarian cancer (OC) cases is caused by germ-line mutations in BRCA1 or BRCA2 genes. BRCA testing is cheap in populations with founder effect and therefore recommended for all patients with OC diagnosis. Recurrent mutations...

Cite
Suspitsin EN, Sherina NY, Ponomariova DN, et al. High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients. Hered Cancer Clin Pract. 2009;7(1):5doi: 10.1186/1897-4287-7-5.
Suspitsin, E. N., Sherina, N. Y., Ponomariova, D. N., Sokolenko, A. P., Iyevleva, A. G., Gorodnova, T. V., Zaitseva, O. A., Yatsuk, O. S., Togo, A. V., Tkachenko, N. N., Shiyanov, G. A., Lobeiko, O. S., Krylova, N. Y., Matsko, D. E., Maximov, S. Y., Urmancheyeva, A. F., Porhanova, N. V., & Imyanitov, E. N. (2009). High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients. Hereditary cancer in clinical practice, 7(1), 5. https://doi.org/10.1186/1897-4287-7-5
Suspitsin, Evgeny N, et al. "High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients." Hereditary cancer in clinical practice vol. 7,1 (2009): 5. doi: https://doi.org/10.1186/1897-4287-7-5
Suspitsin EN, Sherina NY, Ponomariova DN, Sokolenko AP, Iyevleva AG, Gorodnova TV, Zaitseva OA, Yatsuk OS, Togo AV, Tkachenko NN, Shiyanov GA, Lobeiko OS, Krylova NY, Matsko DE, Maximov SY, Urmancheyeva AF, Porhanova NV, Imyanitov EN. High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients. Hered Cancer Clin Pract. 2009 Feb 25;7(1):5. doi: 10.1186/1897-4287-7-5. PMID: 19338682; PMCID: PMC2664323.
Copy Download .nbib Format: NLM
On the mode of integration of plastid-encoded components of the cytochrome bf complex into thylakoid membranes.

Planta

Zak E, Sokolenko A, Unterholzner G, Altschmied L, Herrmann RG.
PMID: 19343411
Planta. 1997 Mar;201(3):334-41. doi: 10.1007/s004250050075.

Four distinct integration/translocation routes into/across thylakoid membranes have recently been deduced for nuclear-encoded polypeptides of the photosynthetic membrane. Corresponding information for the plastid-encoded protein complement is lacking. We have investigated this aspect with in-organello assays employing chimeric constructs generated...

Cite
Zak E, Sokolenko A, Unterholzner G, et al. On the mode of integration of plastid-encoded components of the cytochrome bf complex into thylakoid membranes. Planta. 1997;201(3):334-41doi: 10.1007/s004250050075.
Zak, E., Sokolenko, A., Unterholzner, G., Altschmied, L., & Herrmann, R. G. (1997). On the mode of integration of plastid-encoded components of the cytochrome bf complex into thylakoid membranes. Planta, 201(3), 334-41. https://doi.org/10.1007/s004250050075
Zak, E, et al. "On the mode of integration of plastid-encoded components of the cytochrome bf complex into thylakoid membranes." Planta vol. 201,3 (1997): 334-41. doi: https://doi.org/10.1007/s004250050075
Zak E, Sokolenko A, Unterholzner G, Altschmied L, Herrmann RG. On the mode of integration of plastid-encoded components of the cytochrome bf complex into thylakoid membranes. Planta. 1997 Mar;201(3):334-41. doi: 10.1007/s004250050075. PMID: 19343411.
Copy Download .nbib Format: NLM
Photochemical Synthesis of 2-Azabicyclo[3.2.0]heptanes: Advanced Building Blocks for Drug Discovery. Synthesis of 2,3-Ethanoproline.

The Journal of organic chemistry

Druzhenko T, Skalenko Y, Samoilenko M, Denisenko A, Zozulya S, Borysko PO, Sokolenko MI, Tarasov A, Mykhailiuk PK.
PMID: 29297689
J Org Chem. 2018 Feb 02;83(3):1394-1401. doi: 10.1021/acs.joc.7b02910. Epub 2018 Jan 16.

Intramolecular photochemical [2 + 2]-cyclization of acetophenone enamides gave 2-azabicyclo[3.2.0]heptanes, advanced building blocks for drug discovery. Synthesis of a conformationally restricted analogue of proline, 2,3-ethanoproline, was performed.

Cite
Druzhenko T, Skalenko Y, Samoilenko M, et al. Photochemical Synthesis of 2-Azabicyclo[3.2.0]heptanes: Advanced Building Blocks for Drug Discovery. Synthesis of 2,3-Ethanoproline. J Org Chem. 2018;83(3):1394-1401doi: 10.1021/acs.joc.7b02910.
Druzhenko, T., Skalenko, Y., Samoilenko, M., Denisenko, A., Zozulya, S., Borysko, P. O., Sokolenko, M. I., Tarasov, A., & Mykhailiuk, P. K. (2018). Photochemical Synthesis of 2-Azabicyclo[3.2.0]heptanes: Advanced Building Blocks for Drug Discovery. Synthesis of 2,3-Ethanoproline. The Journal of organic chemistry, 83(3), 1394-1401. https://doi.org/10.1021/acs.joc.7b02910
Druzhenko, Tetiana, et al. "Photochemical Synthesis of 2-Azabicyclo[3.2.0]heptanes: Advanced Building Blocks for Drug Discovery. Synthesis of 2,3-Ethanoproline." The Journal of organic chemistry vol. 83,3 (2018): 1394-1401. doi: https://doi.org/10.1021/acs.joc.7b02910
Druzhenko T, Skalenko Y, Samoilenko M, Denisenko A, Zozulya S, Borysko PO, Sokolenko MI, Tarasov A, Mykhailiuk PK. Photochemical Synthesis of 2-Azabicyclo[3.2.0]heptanes: Advanced Building Blocks for Drug Discovery. Synthesis of 2,3-Ethanoproline. J Org Chem. 2018 Feb 02;83(3):1394-1401. doi: 10.1021/acs.joc.7b02910. Epub 2018 Jan 16. PMID: 29297689.
Copy Download .nbib Format: NLM
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.

Hereditary cancer in clinical practice

Gorodnova TV, Sokolenko AP, Kotiv KB, Sokolova TN, Ivantsov AO, Guseynov KD, Nekrasova EA, Smirnova OA, Berlev IV, Imyanitov EN.
PMID: 33536037
Hered Cancer Clin Pract. 2021 Feb 03;19(1):14. doi: 10.1186/s13053-021-00173-2.

BACKGROUND: Cisplatin, mitomycin C and anthracyclines demonstrate high activity in BRCA1-deficient tumors. This study aimed to evaluate the efficacy of the triplet combination of these drugs in BRCA1-driven high-grade serous ovarian carcinomas (HGSOCs).METHODS: Ten HGSOC patients with germ-line BRCA1...

Cite
Gorodnova TV, Sokolenko AP, Kotiv KB, et al. Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. Hered Cancer Clin Pract. 2021;19(1):14doi: 10.1186/s13053-021-00173-2.
Gorodnova, T. V., Sokolenko, A. P., Kotiv, K. B., Sokolova, T. N., Ivantsov, A. O., Guseynov, K. D., Nekrasova, E. A., Smirnova, O. A., Berlev, I. V., & Imyanitov, E. N. (2021). Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. Hereditary cancer in clinical practice, 19(1), 14. https://doi.org/10.1186/s13053-021-00173-2
Gorodnova, Tatiana V, et al. "Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin." Hereditary cancer in clinical practice vol. 19,1 (2021): 14. doi: https://doi.org/10.1186/s13053-021-00173-2
Gorodnova TV, Sokolenko AP, Kotiv KB, Sokolova TN, Ivantsov AO, Guseynov KD, Nekrasova EA, Smirnova OA, Berlev IV, Imyanitov EN. Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. Hered Cancer Clin Pract. 2021 Feb 03;19(1):14. doi: 10.1186/s13053-021-00173-2. PMID: 33536037; PMCID: PMC7860626.
Copy Download .nbib Format: NLM
High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology.

Behavioural brain research

Miles B, Yang W, Dezsi G, Sokolenko E, Gomes FMM, Jupp B, Hill R, Hudson M, Jones NC.
PMID: 34767903
Behav Brain Res. 2022 Feb 10;418:113665. doi: 10.1016/j.bbr.2021.113665. Epub 2021 Nov 10.

INTRODUCTION: Western diets, including those consisting of saturated fats, simple sugars and processed foods, is rising at an unprecedented rate. These lead to obesity and metabolic diseases, and possibly cognitive deficits. Exploring this, recent studies demonstrate marked impairment in...

Cite
Miles B, Yang W, Dezsi G, et al. High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behav Brain Res. 2021;418:113665doi: 10.1016/j.bbr.2021.113665.
Miles, B., Yang, W., Dezsi, G., Sokolenko, E., Gomes, F. M. M., Jupp, B., Hill, R., Hudson, M., & Jones, N. C. (2022). High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behavioural brain research, 418113665. https://doi.org/10.1016/j.bbr.2021.113665
Miles, Briannah, et al. "High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology." Behavioural brain research vol. 418 (2022): 113665. doi: https://doi.org/10.1016/j.bbr.2021.113665
Miles B, Yang W, Dezsi G, Sokolenko E, Gomes FMM, Jupp B, Hill R, Hudson M, Jones NC. High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behav Brain Res. 2022 Feb 10;418:113665. doi: 10.1016/j.bbr.2021.113665. Epub 2021 Nov 10. PMID: 34767903.
Copy Download .nbib Format: NLM
New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family.

Frontiers in molecular biosciences

Filippova IY, Dvoryakova EA, Sokolenko NI, Simonyan TR, Tereshchenkova VF, Zhiganov NI, Dunaevsky YE, Belozersky MA, Oppert B, Elpidina EN.
PMID: 33195423
Front Mol Biosci. 2020 Oct 22;7:578758. doi: 10.3389/fmolb.2020.578758. eCollection 2020.

New substrates with glutamine in the P1-position are introduced for the assay of peptidases from the C1 papain family, with a general formula of Glp-Phe-Gln-X, where Glp is pyroglutamyl and X is pNA (

Cite
Filippova IY, Dvoryakova EA, Sokolenko NI, et al. New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family. Front Mol Biosci. 2020;7:578758doi: 10.3389/fmolb.2020.578758.
Filippova, I. Y., Dvoryakova, E. A., Sokolenko, N. I., Simonyan, T. R., Tereshchenkova, V. F., Zhiganov, N. I., Dunaevsky, Y. E., Belozersky, M. A., Oppert, B., & Elpidina, E. N. (2020). New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family. Frontiers in molecular biosciences, 7578758. https://doi.org/10.3389/fmolb.2020.578758
Filippova, Irina Y, et al. "New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family." Frontiers in molecular biosciences vol. 7 (2020): 578758. doi: https://doi.org/10.3389/fmolb.2020.578758
Filippova IY, Dvoryakova EA, Sokolenko NI, Simonyan TR, Tereshchenkova VF, Zhiganov NI, Dunaevsky YE, Belozersky MA, Oppert B, Elpidina EN. New Glutamine-Containing Substrates for the Assay of Cysteine Peptidases From the C1 Papain Family. Front Mol Biosci. 2020 Oct 22;7:578758. doi: 10.3389/fmolb.2020.578758. eCollection 2020. PMID: 33195423; PMCID: PMC7643032.
Copy Download .nbib Format: NLM
Iris Vascular Abnormality: Different Forms and Clinical Appearance.

Klinische Monatsblatter fur Augenheilkunde

Sokolenko E, Rydz C, Westekemper H, Bechrakis NE, Fiorentzis M.
PMID: 34674203
Klin Monbl Augenheilkd. 2021 Oct 21; doi: 10.1055/a-1649-7879. Epub 2021 Oct 21.

No abstract available.

Cite
Sokolenko E, Rydz C, Westekemper H, et al. Gefäßanomalie der Iris: verschiedene Formen und klinische Erscheinungsbilder - Fallserie. Iris Vascular Abnormality: Different Forms and Clinical Appearance. Klin Monbl Augenheilkd. 2021;doi: 10.1055/a-1649-7879.
Sokolenko, E., Rydz, C., Westekemper, H., Bechrakis, N. E., & Fiorentzis, M. (2021). Gefäßanomalie der Iris: verschiedene Formen und klinische Erscheinungsbilder - Fallserie. Iris Vascular Abnormality: Different Forms and Clinical Appearance. Klinische Monatsblatter fur Augenheilkunde, . https://doi.org/10.1055/a-1649-7879
Sokolenko, Ekaterina, et al. "Gefäßanomalie der Iris: verschiedene Formen und klinische Erscheinungsbilder - Fallserie." Iris Vascular Abnormality: Different Forms and Clinical Appearance. Klinische Monatsblatter fur Augenheilkunde vol. (2021). doi: https://doi.org/10.1055/a-1649-7879
Sokolenko E, Rydz C, Westekemper H, Bechrakis NE, Fiorentzis M. Gefäßanomalie der Iris: verschiedene Formen und klinische Erscheinungsbilder - Fallserie. Iris Vascular Abnormality: Different Forms and Clinical Appearance. Klin Monbl Augenheilkd. 2021 Oct 21; doi: 10.1055/a-1649-7879. Epub 2021 Oct 21. PMID: 34674203.
Copy Download .nbib Format: NLM
High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology.

Behavioural brain research

Miles B, Yang W, Dezsi G, Sokolenko E, Gomes FMM, Jupp B, Hill R, Hudson M, Jones NC.
PMID: 34767903
Behav Brain Res. 2022 Feb 10;418:113665. doi: 10.1016/j.bbr.2021.113665. Epub 2021 Nov 10.

INTRODUCTION: Western diets, including those consisting of saturated fats, simple sugars and processed foods, is rising at an unprecedented rate. These lead to obesity and metabolic diseases, and possibly cognitive deficits. Exploring this, recent studies demonstrate marked impairment in...

Cite
Miles B, Yang W, Dezsi G, et al. High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behav Brain Res. 2021;418:113665doi: 10.1016/j.bbr.2021.113665.
Miles, B., Yang, W., Dezsi, G., Sokolenko, E., Gomes, F. M. M., Jupp, B., Hill, R., Hudson, M., & Jones, N. C. (2022). High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behavioural brain research, 418113665. https://doi.org/10.1016/j.bbr.2021.113665
Miles, Briannah, et al. "High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology." Behavioural brain research vol. 418 (2022): 113665. doi: https://doi.org/10.1016/j.bbr.2021.113665
Miles B, Yang W, Dezsi G, Sokolenko E, Gomes FMM, Jupp B, Hill R, Hudson M, Jones NC. High sucrose diet does not impact spatial cognition in rats using advanced touchscreen technology. Behav Brain Res. 2022 Feb 10;418:113665. doi: 10.1016/j.bbr.2021.113665. Epub 2021 Nov 10. PMID: 34767903.
Copy Download .nbib Format: NLM
Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed .

Journal of clinical tuberculosis and other mycobacterial diseases

Bourinbaiar AS, Batbold U, Efremenko Y, Sanjagdorj M, Butov D, Damdinpurev N, Grinishina E, Mijiddorj O, Kovolev M, Baasanjav K, Butova T, Prihoda N, Batbold O, Yurchenko L, Tseveendorj A, Arzhanova O, Chunt E, Stepanenko H, Sokolenko N, Makeeva N, Tarakanovskaya M, Borisova V, Reid A, Kalashnikov V, Nyasulu P, Prabowo SA, Jirathitikal V, Bain AI, Stanford C, Stanford J.
PMID: 31890902
J Clin Tuberc Other Mycobact Dis. 2019 Dec 12;18:100141. doi: 10.1016/j.jctube.2019.100141. eCollection 2020 Feb.

OBJECTIVE: Immunotherapy of tuberculosis (TB) to shorten treatment duration represents an unmet medical need. Orally delivered, tableted TB vaccine (V7) containing heat-killed METHODS: The outcome of Phase III trial of V7 containing 10 µg of hydrolyzed RESULTS: After one...

Cite
Bourinbaiar AS, Batbold U, Efremenko Y, et al. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed . J Clin Tuberc Other Mycobact Dis. 2019;18:100141doi: 10.1016/j.jctube.2019.100141.
Bourinbaiar, A. S., Batbold, U., Efremenko, Y., Sanjagdorj, M., Butov, D., Damdinpurev, N., Grinishina, E., Mijiddorj, O., Kovolev, M., Baasanjav, K., Butova, T., Prihoda, N., Batbold, O., Yurchenko, L., Tseveendorj, A., Arzhanova, O., Chunt, E., Stepanenko, H., Sokolenko, N., Makeeva, N., Tarakanovskaya, M., Borisova, V., Reid, A., Kalashnikov, V., Nyasulu, P., Prabowo, S. A., Jirathitikal, V., Bain, A. I., Stanford, C., & Stanford, J. (2020). Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed . Journal of clinical tuberculosis and other mycobacterial diseases, 18100141. https://doi.org/10.1016/j.jctube.2019.100141
Bourinbaiar, Aldar S, et al. "Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed ." Journal of clinical tuberculosis and other mycobacterial diseases vol. 18 (2020): 100141. doi: https://doi.org/10.1016/j.jctube.2019.100141
Bourinbaiar AS, Batbold U, Efremenko Y, Sanjagdorj M, Butov D, Damdinpurev N, Grinishina E, Mijiddorj O, Kovolev M, Baasanjav K, Butova T, Prihoda N, Batbold O, Yurchenko L, Tseveendorj A, Arzhanova O, Chunt E, Stepanenko H, Sokolenko N, Makeeva N, Tarakanovskaya M, Borisova V, Reid A, Kalashnikov V, Nyasulu P, Prabowo SA, Jirathitikal V, Bain AI, Stanford C, Stanford J. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed . J Clin Tuberc Other Mycobact Dis. 2019 Dec 12;18:100141. doi: 10.1016/j.jctube.2019.100141. eCollection 2020 Feb. PMID: 31890902; PMCID: PMC6933248.
Copy Download .nbib Format: NLM
HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan.

Infectious agents and cancer

Adilbay D, Adilbayev G, Kidirbayeva G, Shipilova V, Sadyk Z, Koyanbekova G, Sokolenko E, Klozar J.
PMID: 29344081
Infect Agent Cancer. 2018 Jan 12;13:2. doi: 10.1186/s13027-018-0175-8. eCollection 2018.

BACKGROUND: Human papillomavirus (HPV) is an important etiologic factor in different cancers of anogenital region and also in a fraction of head and neck cancers (HNC) particularly oropharyngeal tumors. The HPV16 genotype associated with the majority of HPV-related head...

Cite
Adilbay D, Adilbayev G, Kidirbayeva G, et al. HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan. Infect Agent Cancer. 2018;13:2doi: 10.1186/s13027-018-0175-8.
Adilbay, D., Adilbayev, G., Kidirbayeva, G., Shipilova, V., Sadyk, Z., Koyanbekova, G., Sokolenko, E., & Klozar, J. (2018). HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan. Infectious agents and cancer, 132. https://doi.org/10.1186/s13027-018-0175-8
Adilbay, Dauren, et al. "HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan." Infectious agents and cancer vol. 13 (2018): 2. doi: https://doi.org/10.1186/s13027-018-0175-8
Adilbay D, Adilbayev G, Kidirbayeva G, Shipilova V, Sadyk Z, Koyanbekova G, Sokolenko E, Klozar J. HPV infection and P16 expression in oral and oropharyngeal cancer in Kazakhstan. Infect Agent Cancer. 2018 Jan 12;13:2. doi: 10.1186/s13027-018-0175-8. eCollection 2018. PMID: 29344081; PMCID: PMC5767046.
Copy Download .nbib Format: NLM
Hereditary breast-ovarian cancer syndrome in Russia.

Acta naturae

Sokolenko AP, Iyevleva AG, Mitiushkina NV, Suspitsin EN, Preobrazhenskaya EV, Kuligina ESh, Voskresenskiy DA, Lobeiko OS, Krylova NY, Gorodnova TV, Buslov KG, Bit-Sava EM, Dolmatov GD, Porhanova NV, Polyakov IS, Abysheva SN, Katanugina AS, Baholdin DV, Yanus GA, Togo AV, Moiseyenko VM, Maximov SY, Semiglazov VF, Imyanitov EN.
PMID: 22649661
Acta Naturae. 2010 Oct;2(4):31-5.

Hereditary breast-ovarian cancer syndrome contributes to as much as 5-7% of breast cancer (BC) and 10-15% of ovarian cancer (OC) incidence. Mutations in the "canonical" genesBRCA1andBRCA2occur in 20-30% of affected pedigrees. In addition toBRCA1andBRCA2 mutations, germ-line lesions in theCHEK2,NBS1,...

Cite
Sokolenko AP, Iyevleva AG, Mitiushkina NV, et al. Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae. 2010;2(4):31-5
Sokolenko, A. P., Iyevleva, A. G., Mitiushkina, N. V., Suspitsin, E. N., Preobrazhenskaya, E. V., Kuligina, E. S. h., Voskresenskiy, D. A., Lobeiko, O. S., Krylova, N. Y., Gorodnova, T. V., Buslov, K. G., Bit-Sava, E. M., Dolmatov, G. D., Porhanova, N. V., Polyakov, I. S., Abysheva, S. N., Katanugina, A. S., Baholdin, D. V., Yanus, G. A., Togo, A. V., Moiseyenko, V. M., Maximov, S. Y., Semiglazov, V. F., & Imyanitov, E. N. (2010). Hereditary breast-ovarian cancer syndrome in Russia. Acta naturae, 2(4), 31-5.
Sokolenko, A P, et al. "Hereditary breast-ovarian cancer syndrome in Russia." Acta naturae vol. 2,4 (2010): 31-5.
Sokolenko AP, Iyevleva AG, Mitiushkina NV, Suspitsin EN, Preobrazhenskaya EV, Kuligina ESh, Voskresenskiy DA, Lobeiko OS, Krylova NY, Gorodnova TV, Buslov KG, Bit-Sava EM, Dolmatov GD, Porhanova NV, Polyakov IS, Abysheva SN, Katanugina AS, Baholdin DV, Yanus GA, Togo AV, Moiseyenko VM, Maximov SY, Semiglazov VF, Imyanitov EN. Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae. 2010 Oct;2(4):31-5. PMID: 22649661; PMCID: PMC3347586.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 39 entries